These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8692517)

  • 1. Color and pulsed Doppler sonography, gray-scale imaging, and serum CA 125 in the assessment of adnexal disease.
    Predanic M; Vlahos N; Pennisi JA; Moukhtar M; Aleem FA
    Obstet Gynecol; 1996 Aug; 88(2):283-8. PubMed ID: 8692517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
    Salem S; White LM; Lai J
    AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
    Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
    AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study.
    Guerriero S; Alcazar JL; Coccia ME; Ajossa S; Scarselli G; Boi M; Gerada M; Melis GB
    J Ultrasound Med; 2002 Oct; 21(10):1105-11. PubMed ID: 12369665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difficulties in differential diagnosis of adnexal masses during pregnancy: the role of greyscale and color doppler sonography].
    Czekierdowski A; Bednarek W; Rogowska W; Kotarski J
    Ginekol Pol; 2001 Dec; 72(12A):1281-6. PubMed ID: 11883264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
    Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrectal sonography in staging rectal carcinoma: the role of gray-scale, color-flow, and Doppler imaging analysis.
    Heneghan JP; Salem RR; Lange RC; Taylor KJ; Hammers LW
    AJR Am J Roentgenol; 1997 Nov; 169(5):1247-52. PubMed ID: 9353436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
    Testa AC; Timmerman D; Van Belle V; Fruscella E; Van Holsbeke C; Savelli L; Ferrazzi E; Leone FP; Marret H; Tranquart F; Exacoustos C; Nazzaro G; Bokor D; Magri F; Van Huffel S; Ferrandina G; Valentin L
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):699-710. PubMed ID: 19924735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses.
    Schneider VL; Schneider A; Reed KL; Hatch KD
    Obstet Gynecol; 1993 Jun; 81(6):983-8. PubMed ID: 8497367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone.
    Buy JN; Ghossain MA; Hugol D; Hassen K; Sciot C; Truc JB; Poitout P; Vadrot D
    AJR Am J Roentgenol; 1996 Feb; 166(2):385-93. PubMed ID: 8553953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women.
    Strigini FA; Gadducci A; Del Bravo B; Ferdeghini M; Genazzani AR
    Gynecol Oncol; 1996 Apr; 61(1):68-72. PubMed ID: 8626120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding cancer antigen 125 screening to gray scale sonography for predicting specific diagnosis of benign adnexal masses in premenopausal women: is it worthwhile?
    Alcázar JL; Guerriero S; Mínguez JÁ; Ajossa S; Paoletti AM; Ruiz-Zambrana A; Jurado M
    J Ultrasound Med; 2011 Oct; 30(10):1381-6. PubMed ID: 21968488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler ultrasound assessment and serum cancer antigen 125 in the diagnosis of ovarian tumors.
    Erdoğan N; Ozçelik B; Serin IS; Akgün M; Oztürk F
    Int J Gynaecol Obstet; 2005 Nov; 91(2):146-50. PubMed ID: 16083888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.